Randomized Control Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty
IRB Number: 2015-067
not enrolling new patientsMay 20, 2015
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
Co-Investigators
- Michael B. Cross, MD
- Seth A. Jerabek, MD
- Kaitlin M. Carroll, BS
- Joseph Nguyen
- Liz Niedbala
Summary
The study will begin when IRB approval is granted and will continue until 50 patients are recruited. Follow-up will be for 1 year after the indexed surgical intervention.
Inclusion/Exclusion Criteria
The study will begin when IRB approval is granted and will continue until 50 patients are recruited. Follow-up will be for 1 year after the indexed surgical intervention.
Contact Information
David J. Mayman MD
maymand@hss.edu
212.774.2024